Clinical Trials Logo

Fatigue clinical trials

View clinical trials related to Fatigue.

Filter by:

NCT ID: NCT00181129 Completed - Cancer Clinical Trials

Fatigue and Cancer Treatment(FACT)- an Exercise Intervention

Start date: September 2002
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to determine the effects of a nurse-directed, home-based walking exercise program to mitigate fatigue and maintain physical functioning during adjuvant therapy for cancer. The sample will be randomized into exercise (EX) or usual care (UC) groups. The independent study variable is participation in a walking exercise program. Outcomes include: fatigue, sleep disturbance, emotional distress, physical functioning and quality of life. The effects of the walking exercise program will be evaluated using self-report questionnaires administered pre- and post-treatment, patient diaries, and symptoms assessments at defined intervals during adjuvant therapy

NCT ID: NCT00179348 Completed - Depression Clinical Trials

Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer

Start date: February 8, 2001
Phase: N/A
Study type: Interventional

This clinical trial studies yoga-based rehabilitation in reducing physical and emotional side effects of living with cancer or its treatment. Yoga-based rehabilitation may reduce side effects and improve the quality of life of patients with breast, lung, or colorectal cancer.

NCT ID: NCT00178373 Completed - Cancer Clinical Trials

Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

Start date: May 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy of modafinil with regard to reducing cancer-related fatigue in cancer patients following chemotherapy or radiation therapy. Secondarily, the effect of modafinil on cognitive dysfunction in the same population will be assessed. The researchers hypothesize that administering modafinil (PROVIGIL®) to patients experiencing fatigue following completion of cancer treatment will lead to reduction in patient fatigue and prevention of or improvement in patient cognitive dysfunction.

NCT ID: NCT00178204 Completed - Cancer Clinical Trials

Sleep Architecture and Chemotherapy-Related Fatigue

Start date: November 2004
Phase: N/A
Study type: Observational

The purpose of this study is to identify specific chemotherapy-related changes in sleep stages/architecture that may relate to an increase in fatigue in individuals with cancer. The researchers hypothesize that the fatigue experienced by cancer patients receiving chemotherapy is in part due to changes in restorative sleeping during the non-rapid eye movement cycles of sleep (i.e., delta activity).

NCT ID: NCT00177840 Completed - Fatigue Clinical Trials

Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients

Start date: September 2005
Phase: Phase 1
Study type: Interventional

This study will evaluate if acupuncture is helpful in treating cancer-related fatigue in breast cancer patients undergoing radiation therapy.

NCT ID: NCT00156871 Completed - Fatigue Clinical Trials

Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

Start date: April 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the impact of fatigue in severely affected transplant patients.

NCT ID: NCT00144235 Completed - Mental Fatigue Clinical Trials

Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue

Start date: March 2005
Phase: Phase 3
Study type: Interventional

To assess the efficacy and safety of Pharmaton? PHL 00749 in improving cognitive function and allevi ating mental and physical stress in healthy male and female subjects leading demanding lifestyles.

NCT ID: NCT00138138 Completed - Prostate Cancer Clinical Trials

Psychostimulants for Fatigue in Prostate Cancer

Start date: October 2002
Phase: Phase 2
Study type: Interventional

Fatigue is one of the most common symptoms of prostate cancer. Fatigue is a lack of energy that makes it harder to do the things you normally do every day. Some symptoms of fatigue are: - feeling tired and/or weak; - having less interest in activities; - having trouble concentrating; - feeling "down"; - feeling exhausted for no clear reason. There are not many drugs that are helpful in treating fatigue. However, one group of medications does seem to be useful. In this study, we, the investigators at Memorial Sloan-Kettering Cancer Center, will be using a psychostimulant called Ritalin. The aim of this study is to see if this drug is helpful in treating fatigue in prostate cancer. We are also studying the side effects of this medication.

NCT ID: NCT00118378 Completed - HIV Infections Clinical Trials

Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS

Start date: December 2004
Phase: Phase 4
Study type: Interventional

This study will determine whether modafinil (Provigil®), a medication approved for the treatment of narcolepsy, is effective in reducing fatigue in adults with HIV/AIDS.

NCT ID: NCT00113906 Completed - Fatigue Clinical Trials

Melatonin Treatment After Laparoscopic Cholecystectomy

Start date: March 2005
Phase: Phase 2/Phase 3
Study type: Interventional

Circadian disturbances occur after surgery. A double blinded, placebo controlled randomized clinical trial was made to investigate effects of melatonin on postoperative fatigue, sleep disturbances and general wellbeing.